Immunogenicity of human embryonic stem cell-derived beta cells

AIMS/HYPOTHESIS: To overcome the donor shortage in the treatment of advanced type 1 diabetes by islet transplantation, human embryonic stem cells (hESCs) show great potential as an unlimited alternative source of beta cells. hESCs may have immune privileged properties and it is important to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Torren, Cornelis R., Zaldumbide, Arnaud, Duinkerken, Gaby, Brand-Schaaf, Simone H., Peakman, Mark, Stangé, Geert, Martinson, Laura, Kroon, Evert, Brandon, Eugene P., Pipeleers, Daniel, Roep, Bart O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518073/
https://www.ncbi.nlm.nih.gov/pubmed/27787618
http://dx.doi.org/10.1007/s00125-016-4125-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518073/
https://www.ncbi.nlm.nih.gov/pubmed/27787618
http://dx.doi.org/10.1007/s00125-016-4125-y

Ejemplares similares